Neurovalens raises £1.1 million for its wearable brain stimulation device

Northern Ireland-based health tech startup Neurovalens has raised a seed round of £1.1 million to accelerate the production of its wearable device for stimulating the brain.

The funding comes from Angel CoFund, Beltrae Partners, and TechStart NI.

The funding will allow the company to move from prototyping to full production. It will be launching its first product, Modius, a wearable device for stimulating the brain’s hunger and metabolism functions, through an Indiegogo crowdfunding campaign where it will seek to raise $50,000.

“Modius is part of an exciting second generation of wearable tech and is a product that actually and actively improves health rather than simply measuring,” said Jason McKeown, CEO of Neurovalens.

“Millions of people want to be leaner and fitter, and by combining the founders knowledge in the disciplines of neuroscience and technology have developed a radically innovative solution for an age-old issue. One that we hope will become a new normal in the individual pursuit of good health,” commented Tim Mills, investment director of Angel CoFund.